These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of the asthmogenicity of propafenone, a new antiarrhythmic drug. Comparison of spirometry with methacholine challenge. Hill MR; Gotz VP; Harman E; McLeod I; Hendeles L Chest; 1986 Nov; 90(5):698-702. PubMed ID: 3533454 [TBL] [Abstract][Full Text] [Related]
3. Theophylline toxicity after propafenone treatment: evidence for drug interaction. Lee BL; Dohrmann ML Clin Pharmacol Ther; 1992 Mar; 51(3):353-5. PubMed ID: 1544292 [No Abstract] [Full Text] [Related]
4. [When are bronchodilator agents sufficient in asthma/chronic obstructive pulmonary disease?]. van Schayck CP; van Herwaarden CL; Folgering H; Akkermans R; van Weel C Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1580-3. PubMed ID: 7675140 [No Abstract] [Full Text] [Related]
5. Severe reactive airways disease induced by propafenone. Olm M; Munne P; Jimenez MJ Chest; 1989 Jun; 95(6):1366-7. PubMed ID: 2721285 [No Abstract] [Full Text] [Related]
6. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease. Hahn DL N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868 [No Abstract] [Full Text] [Related]
7. EUROSCOP, ISOLDE and the Copenhagen city lung study. Burge PS Thorax; 1999 Apr; 54(4):287-8. PubMed ID: 10092687 [No Abstract] [Full Text] [Related]
8. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705 [TBL] [Abstract][Full Text] [Related]
9. Inhaled glucocorticoids in chronic obstructive pulmonary disease. Mapp CE N Engl J Med; 2000 Dec; 343(26):1960-1. PubMed ID: 11136268 [No Abstract] [Full Text] [Related]
10. FVC response in bronchoreversibility test. Chhabra SK Indian J Chest Dis Allied Sci; 2001; 43(1):9-11. PubMed ID: 11370510 [No Abstract] [Full Text] [Related]
11. Bronchodilators in COPD. Yernault JC; Noseda A Thorax; 1994 Nov; 49(11):1182-3. PubMed ID: 7831645 [No Abstract] [Full Text] [Related]
12. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid]. Vestbo J; Lange P Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457 [No Abstract] [Full Text] [Related]
13. [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma]. Dor A; Krasnowska M; MaĆolepszy J Pneumonol Alergol Pol; 1994; 62(1-2):75-9. PubMed ID: 8075617 [TBL] [Abstract][Full Text] [Related]
14. Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease. Calverley PM Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):341-2; discussion 344. PubMed ID: 10673165 [No Abstract] [Full Text] [Related]
15. Inhaled corticosteroids in COPD. Sherwood Burge P Thorax; 1999 Jul; 54(7):655-6. PubMed ID: 10438305 [No Abstract] [Full Text] [Related]
16. Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease. Wedzicha JA Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S23-7. PubMed ID: 10943634 [No Abstract] [Full Text] [Related]
17. Inhaled triamcinolone and chronic obstructive pulmonary disease. Reid DW; Walters H N Engl J Med; 2001 May; 344(20):1554; author reply 1554-6. PubMed ID: 11368047 [No Abstract] [Full Text] [Related]